Nilesh Jain The Board of Directors Makers Laboratories Limited 54-D, Kandivli Industrial Estate Kandivli (W) Mumbai 400 067 Dear Sir, E-5-10, Jai Taramani C.H.S, Bangur Nagar, Goregaon (W). Mumbai - 104 June 1,2020 I shall be retiring as a Director at the ensuing Annual General, Meeting of the Company. I hereby give my consent to continue to act as a Director of the Company,if re-appointed. Thankingyou Yours faithfully • J It ~-.:J~ ~~ -, / Nilesh Jain
Transcript
Nilesh Jain
The Board of DirectorsMakers Laboratories Limited54-D, Kandivli Industrial EstateKandivli (W)Mumbai 400 067
Dear Sir,
E-5-10, Jai Taramani C.H.S,Bangur Nagar, Goregaon (W).Mumbai - 104
June 1, 2020
I shall be retiring as a Director at the ensuing Annual General, Meeting ofthe Company.
I hereby give my consent to continue to act as a Director of the Company,ifre-appointed.
AG~EEMENT made at Mumbai this 15th day. of June, 2020 BETWEEN Makers
Latiratories Limited a Company incorporated under the Companies Act, 1956 and,having its Registered office at 54-0, Kandivli Industrial Estate, Kandivli (West), Mumbai
40~067 (hereinafter referred to as "the Company" which expression shall, unless there
is anything repugnant in the subject or context mean and include its successors and
ass~ns) of the One Part
AND
2
WHEREAS Mr. Saahil Parikh was re-appointed as the Wholetime Director of the
Company for a period of 3 years with effect from 11th August, 2020 at the Meeting of
the Board of Directors of the Company held on 15th June, 2020 subject to compliance
with Sections 196, 197, 203 and Schedule V and other applicable provisions, if any,
of the Companies Act, 2013 and also subject to the approval of the Shareholders.
NOW IT IS HEREBY AGREED BY AND BETWEEN THE PARTIES HERETO AS
FOllOWS:
1. Mr. Saahil Parikh is hereby re-appointed as Wholetime Director of the Company, for
a period of 3 (three) years with effect from 11th August, 2020 subject to the
appointment being previously determined in pursuance of any of the provisions of
this Agreement.
2. The Wholetime Director shall exercise and perform such powers and duties as the
Board shall from time to time, determine, and subject to any directions and
restrictions, from time to time, given and imposed by the Board and perform all other
acts, deeds and things which, in the ordinary course of business, he may consider
necessary or proper in the interest of the Company.
3. The Wholetime Director shall devote his whole-time attention and abilities to the
business of the Company and shall obey the orders, from time to time, of the Board
and in all respects confirm to and comply with the directions and regulations made
by the Board, and shall use his best endeavors to promote interests of the
Company.
4. During the period of his employment the Wholetime Director shall whenever required
by the Company undertake such travelling in India and elsewhere as the Board may
from time to time direct in connection with or in relation to the business of the
Company.
5. The Company shall, in consideration of the performance of his duties, pay to the
Wholetime Director during the continuance of this Agreement, the following
remuneration:
a. Salary of RS.2,60,0001- (Rupees Two lacs Sixty Thousand Only) per month with
such increments as may be decided by the Board subject to a ceiling of
Rs. 3,30,0001- (Rupees Three lacs Thirty Thousand Only) per month.
3
b. Commission: Such remuneration by way of commission, in addition to the above
salary and perquisites, calculated with reference to the net profits of the
Company in a particular financial year and as may be determined by the Board of
Directors of the Company, subject to the overall ceilings stipulated Sections 197
and other applicable provisions of the Companies Act, 2013.
The specific amount payable to the Wholetime Director will be based on certain
performance criteria to be laid down by the Board and will be payable annually
after annual accounts have been adopted by the shareholders.
c. Perquisites: In addition to the salary and commission the Wholetime Director
shall be entitled to the following perquisites:
i. Housing: The expenditure incurred by the Company on hiring furnished
accommodation for the Wholetime Director will be subject to a maximum of
thirty per cent of the Salary. In case no accommodation is provided by the
Company, the Wholetime Director shall be entitled to the house rent
allowance subject to the said ceiling of 30% of the salary.
Explanation: The expenditure incurred by the Company on gas, electricity,
water and furnishings shall be valued as per the Income-Tax Rules, 1962.
This shall, however, be subject to a ceiling of ten per cent of the salary of the
Wholetime Director.
ii. Medical, Hospitalization and Health-care expenses Reimbursement:
Expenses incurred for the Wholetime Director and his family to be paid in
accordance with any rules specified by the Company subject to a ceiling of
Rs. 35,0001- per annum.
iii. Leave Travel Concession: For the Wholetime Director and his family, once in
a year incurred in accordance with any rules specified by the Company
subject to a ceiling of 1 month salary.
iv. Personal accident insurance: As per the Rules specified by the Company.
v. Provident Fund: Company's contribution to Provident Fund shall be as per the
scheme applicable to the employees of the Company.
l
6.
7.
4
vi. Contribution to National Pension Scheme: Company's contribution to any
superannuation fund or national pension scheme shall be in accordance with
the rules of the scheme as may be applicable or as may be framed / decided
by the Company.
Contribution to provident fund I superannuation fund and national pension
scheme will not be included in the computation of perquisites to the extent
these either singly or put together are not taxable under the Income-tax Act.
vii. Gratuity: As per the rules of the Company, payable in accordance with the
Approved Gratuity Fund and which shall not exceed half a month's salary for
each completed year of service.
Contribution to provident fund and gratuity will not be included in the
computation of perquisites.
viii. Encashment of Leave: Encashment of Leave at the end of the tenure of the
Wholetime Director will not be included in the computation of perquisites.
ix. Car: Provision of car for use on Company's business is not to be considered
as perquisites.
x. Telephone: Telephone(s) at the residence of the Wholetime Director and
mobile phone(s) for official use is not to be considered as perquisites.
In the event of no profit or inadequacy of profits, the Company shall pay the
aforesaid remuneration to the Wholetime Director by way of salary and
perquisites as minimum remuneration.
The Wholetime Director shall be entitled to annual privilege leave on full salary
for a period of thirty days and such leave shall be allowed to be accumulated for
not more than ninety days . 's tenure of appointment.OltA 0
,,?:~r-'/.~r gUMBA1'r
I .~:
'.
5
8. The Wholetime Director shall be entitled to :
a) the reimbursement of entertainment expenses actually and properly incurred
by him in the course of the legitimate business of the Company in
accordance with the rules and regulations of the Company in force from time
to time or as may be approved by the Board of Directors; and
b) the reimbursement of travelling, hotel and other expenses incurred by him in
India and abroad exclusively on the business of the Company in accordance
with the rules and regulations of the Company in force from time to time or as
approved by the Board of Directors.
9. The Wholetime Director shall devote his whole-time attention and abilities to the
business of the Company and shall obey the orders, from time to time, of the
Board and in all respects confirm to and comply with the directions and
regulations made by the Board, and shall use his best endeavors to promote
interests of the Company.
10. As long as Mr. Saahil Parikh functions as the Wholetime Director, he shall not be
paid any sitting fee for attending the Meetings of the Board of Directors or
Committee thereof.
11. As long as Mr. Saahil Parikh functions as Wholetime Director, he shall not
become interested or otherwise concerned directly or through his wife and/or
children, in any selling agency of the Company except with the consent of the
Company accorded by a special resolution and the approval of the Central
Government.
12. The Wholetime Director shall not during the continuance of his employment with
the Company or at any time thereafter divulge or disclose to any person
whomsoever or to make any use whatsoever for his own purpose or for any
purpose other than that of the Company or any information or knowledge
obtained by him during his employment as to the business or affairs of the
Company or its methods or as to any trade secrets, or secret processes of the
Company and the Wholetime Director shall during the continuance of his
employment hereun r also use his best endeavor to prevent any other person
'.
13.
14.
15.
16.
17.
6
from so doing provided however that such divulgence or disclosure by the
Wholetime Director to officers and employees of the Company for the purpose of
business of the Company shall not be deemed to be contravention of this clause.
Any property of the company or relating to the business of the Company,
including memoranda, notes, records, reports, plates, sketches, plans, recorded
diskettes, drives, tapes, electronic memory gadgets or other documents which
may be in the possession of or under the control of the Wholetime Director or to
which the Wholetime Director has, at any time access shall, at the time of the
termination of his employment be delivered by the Wholetime Director to the
Company or as it shall direct and the Wholetime Director shall not be entitled to
the copyright in any such document which he hereby acknowledges to be vested,in the Company or its assigns and binds himself not to retain copies of any of
them.
If the Wholetime Director shall at any time be prevented by ill health or accident
or any physical or mental disability from performing his duties hereunder, he shall
inform the Company and supply it with such details as it may reasonably require
and if he shall be unable by reasons of ill health or accident or disability for a
period of 90 days in any period of twelve consecutive calendar months, to
perform his duties hereunder the Company may forthwith terminate his
employment.
The Company shall be entitled to forthwith terminate the agreement if he
becomes insolvent or makes any composition or arrangement with his creditors
or he ceases to be a Director of the Company.
In case of death of the Wholetime Director in the course of his employment with
the Company, the Company shall pay to his legal representati~es the salary and
other emoluments payable hereunder for the then current mbnth together with
any such further sum as the Board in its sole and uncontrolled discretion may
determine.
If the Wholetime Director is guilty of inattention to or negligence in the conduct of
the business or of any other act or omission inconsistent with his duties as
Wholetime t Fir. any breach of this Agreement which in the opinion of,p --::.1~
~
l
..7
the Board renders his retirement from the office of Wholetime Director desirable,
the Company by not less than thirty days notice in writing to the Wholetime
Director determine this Agreement and upon the expiration of such notice the
Wholetime Director shall cease to be the Director of the Company.
18. Notwithstanding anything to the contrary contained in the Agreement, either party
shall be entitled to terminate the Agreement, at anytime by giving to the other
party 60 days notice in writing in that behalf without the necessity of showing any
cause and on the expiry of the period of such notice this Agreement shall stand
determined and the Wholetime Director shall cease to be the Director of the
Company. Provided that the aforesaid notice may, be waived mutually by the
parties hereto.
19. The terms and conditions including the remuneration payable to the Wholetime
Director of the said appointment and/or Agreement may be altered and varied
from time to time by the Board as it may, in its discretion, deem fit.
20. This Agreement represents the entire agreement, between the parties hereto on
the subject matter thereof.
IN WITNESS WHEREOF the parties hereto have set their hands on the day, month and
year hereinabove mentioned.
The Common Seal of Makers Laboratories Limited has
been affixed hereunto in the presence of Mr. Nilesh
Jain, Wholetime Director who has been duly authorised
for the purpose by a Resolution of Board of Directors of
the Company passed at the Meeting held on 15th June,
Sub: Proposed appointment as Cost Auditors, for the Financial Year commencing 1.4.2020Re: Certificate w.rt compliances under Section 139 read with section 148 of the Companies Act,
2013Re: Certificate w.rt arms length relationship
Dear Sir,
With reference to the proposal for re-appointment as Cost Auditors of Maker Laboratories Ltd. ("theCompany") for the financial year commencing 1st April, 2020, please consider this certificate as ourconsent, in terms of the requirements of section 139 of the Companies Act, 2013 ("the Act"), to act assuch Cost Auditors if so appointed by the Board of Directors of the Company.
We would like to inform you that we do not suffer from any disqualifications as specified,inter alia, under the provisions of section 141 of the Act, read with sections 139 and 148of the Act. We further confirm that the appointment, if made, will be within the limitsprescribed under the provisions of section 141(3)(g) read with section 148 of the Act.We would also like to inform you that the sole proprietor of the firm holds the Certificateof Practice issued by the Institute of Cost Accountants of India and is in whole timepractice. Our Permanent Account Number is AAOPP8816H.
We further certify that we are an independent firm of Cost Accountants and are at arm'slength relationship with the Company, and further confirm that there are no orders orproceedings which are pending against our firm or the sole proprietor, relating toprofessional matters of conduct, before the Institute of Cost Accountants of India or anycompetent authority or any court.
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
1
2 20/11/2019EVSE READY INDIA PRIVATE
LIMITED
Name of the CompanySecurities have been
pledged or any
encumbrance has been
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized (2)
KREBS BIOCHEMICALS AND
INDUSTRIES LIMITED 12/02/2016
Other consideration paid
for acquisitionS. No.
Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition (16)
Name of the Company Date of Cessation
Date of birth : 22.03.1949 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : ABHPV6666R
Residential address:
Present: Flat No. 1902, Challenger Tower-2, Thakur Village, Kandivali (E), Mumbai- 400101, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Kamal Kishore Prasad Verma
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Late. Lal Mani Verma Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Nilam Verma Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '02166789 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Raj Kamal Prasad Verma Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
1
2
3
Name of the CompanySecurities have been
pledged or any
encumbrance has been
SAM TAX AND FINANCE
SERVICES PRIVATE LIMITED
AVIK PHARMACEUTICAL
LIMITED
24/12/2002
17/09/2014
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized
RAVI KUMAR DISTILLERIES
LIMITED
03/11/2010
Other consideration paid
for acquisition
(2)
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition (16)
Name of the Company Date of Cessation
Date of birth : 21.06.1953 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AAEPK4407B
Residential address:
Present: 601, 6th Floor, Rustomjee Ozone CHS Ltd. Tower NO.6, Link Road, Goregaon (West), Mumbai - 400 104, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Mukanchand Kathariya
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Mrs. Khamabai Kathariya Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Asha Kathariya Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '00281395 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Popatlal Mukanchand Kathariya Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other
consideration
paid for
acquisition
Date of
disposal
Price
received
on
disposal
Other
considerat
ion
received
on
disposal
Cumulativ
e balance
and
number of
securities
held after
each
Mode of
acquisitio
n of
securities
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisitio
n
Price paid
for
acquisitio
n of
securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
Date of birth : 24.06.1973 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : N.A.
Residential address:
Present: Jai Bhagwan Building, 3rd Floor, Flat no. 10, 87, Walkeshwar Road, Near White House Mallabar Hills, Mumbai
400006, Maharashtra, India
Permanent: Same as Present
Father's Name : Mr. Chinubhai Dahyalal Shah
Date of appointment and reappointment in the company : Appointment - 29/01/2018
Regularisation : 02/08/2018
Mother's Name : Mrs. Kanchanben Shah Date of cessation of office and reasons therefor :
Spouse's Name (If married) : - Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : 07995542 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Ms. Dipti Chinubhai Shah Occupation : Lawyer
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 29/01/2018
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Office of director or KMP held or relinquished in any other body corporate :
Sr. No. Date of Appointment
Name of the CompanySecurities have been
pledged or any
encumbrance has been
Date of
disposal
Price
received
on
Other
considerat
ion
Cumulativ
e balance
and
Mode of
acquisition
of
Mode of holding
– physical or
dematerialized (2)
-
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisition
Other consideration paid
for acquisition
(16)
Name of the Company Date of Cessation
Date of birth : 28.04.1975 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : AACPJ1539R
Residential address:
Present: E-5-10, Jai Taramani C.H.S, Bangur Nagar, Goregaon (W). Mumbai- 104, Maharashtra, India. Permanent: Same as Present
Father's Name : Mr. Shivraj Anchalya
Date of appointment and reappointment in the company : Appointment - 13.02.2019
Regularisation: 08.08.2019
Mother's Name : Mrs. Chanda Anchalya Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Pooja Jain Office of director or KMP held or relinquished in any other body corporate : N.A
Director Identification Number (optional for key managerial personnel) : '05263110 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Nilesh Jain Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made : 13.02.2019
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
Office of director or KMP held or relinquished in any other body corporate :
Sr. No.
Mode of
holding –
physical or
dematerialized
form
Name of the Company
Securities have been
pledged or any
encumbrance has
been created
Other
consideration
paid for
acquisition
Date of
disposal
Price
received
on
disposal
Other
considerat
ion
received
on
disposal
Cumulativ
e balance
and
number of
securities
held after
each
Mode of
acquisitio
n of
securities
S. No.Number of
Securities
Descriptio
n of
Securities
Nominal
Value of
Securities
Date of
Acquisition
Price paid
for
acquisitio
n of
securities
Name of the Company Date of Appointment Date of Cessation
-
(2) (16)
no
no
no
Makers Laboratories
Limited
Date of birth : 27.01.1975 Membership number of the ICSI in case of Company Secretary, if applicable: N.A.
Permanent Account Number (mandatory for KMP if not having DIN) : N.A.
Residential address:
Present: 3, Shailraj Bunglows, B/H Rajsuya Bunglows, Ramdevnagar, Satellite, Ahmedabad, 380015, Gujrat, India Permenent: Same as Present
Father's Name : Mr. Umesh Shantilal Parikh
Date of appointment and reappointment in the company : Appointment - 11.08.2011 ; Re-
appointment: 11.08.2017
Mother's Name : Mrs. Dhanishtha Parikh Date of cessation of office and reasons therefor :
Spouse's Name (If married) : Mrs. Radhika Parikh Office of director or KMP held or relinquished in any other body corporate :
Director Identification Number (optional for key managerial personnel) : 00400079 Nationality (including the nationality of origin, if different) : Indian
Present name and surname in full : Mr. Saahil Umesh Parikh Occupation : Service
Any former name or surname in full : N.A. Date of the board resolution in which the appointment was made :
Register of Directors and Key Managerial Personnel and their Shareholding
[Pursuant to section 88 (1)(a) of the Companies Act, 2013 and rule 3(1) of the Companies (Management and Administration) Rules, 2014]
YES BANK LIMITED Nehru Centre, 9th Floor, Discovery of India Dr. A.B. Road,Worli, Mumbai 400 018
The facility will be covered by exclusive Charge on plant and machinery located at new ophthalmic products manufacturing facility at Naroda, Ahmedabad. More particularly described in schedule II to DOH
Deed of Hypothecation dated 25/09/2018
NA NA NA NA NA NA NA NA
2 100279254 10/07/2019 05/08/2019 Immovable property as more particularly described in schedule II to MoE
YES BANK LIMITED Nehru Centre, 9th Floor, Discovery of India Dr. A.B. Road,Worli, Mumbai 400 018
The facility will be covered by exclusive Charge on immovable property as more particularly described in schedule II to MoE
Memorandum of Equitable Mortgage by Deposit of Title Deeds dated 10/07/2019
NA NA NA NA NA NA NA NA
MAKERS LABORATORIES LIMITED
REGISTER OF CHARGES[Pursuant to Section 85 sub rule (1) of the rule 10 of the Companies (Registration of Charges) Rules, 2014]
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested
[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Name of
the
Interested
Director
Relation
with
Director /
Company /
Nature of
concern or
Interest
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested
[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Name of
the
Interested
Director
Relation
with
Director /
Company /
Nature of
concern or
Interest
to Inv Date Amt
30.06.2019 431LS90012 24/06/2019 230,927
431LS90013 26/06/2019 347,417
431LS90014 26/06/2019 354,399
405LS9000064 18/05/2019 16,281
406LS9000126 07/06/2019 1,478
01.04.2019 08.08.2019
to Inv Date Amt
30.06.2019 113LS900098 25/05/2019 4,248,000
08.08.2019
Inv Date Amt
DA-05 10/06/2019 (53,985.00)
P. M. Kathariya Dipti Shah Nilesh JainR.K. P. Verma Saahil Parikh
Income/Expenditure
Ipca
Laboratories
Limited
Ipca
Laboratories
Limited
Entries made are hereby approved
Details of Purchase
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Details of Sales
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
Date of
approval
at the
meeting of
the Board
Signature Remarks,if
any
Principal terms and conditions Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolution
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
Date of
approval
at the
meeting of
the Board
Signature Remarks,if
any
Principal terms and conditions Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
01.07.2019 06.11.2019
to Inv Date Amt
30.09.2019 431LS90015 24.07.2019 761,608
431LS90016 26.07.2019 351,187
431LS90018 14.08.2019 267,700
431LS90019 14.08.2019 137,760
431LS90020 16.08.2019 131,040
431LS90021 16.08.2019 591,977
431LS90022 19.08.2019 275,176
431LS90023 07.09.2019 346,138
431LS90024 14.09.2019 471,205
431LS90025 15.09.2019 94,584
01.07.2019 06.11.2019
to Inv Date Amt
30.09.2019 102LS900911 27.08.2019 401,200
102LS900973 09.09.2019 615,842
06.11.2019
Inv Date AmtDA-10 22.07.2019 (68,281.00) DA-15 27.08.2019 (9,723.00)
P. M. Kathariya Dipti Shah Nilesh Jain
Ipca
Laboratories
Limited
Ipca
Laboratories
Limited
R.K. P. Verma Saahil Parikh
Details of Manufacturing Charges
Details of Purchase
Income/Expenditure
Entries made are hereby approved
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Details of SalesIpca
Laboratories
Limited
Reference
of specific
items - (a)
to (g) under
sub-section
(1) of
section 188
(5)
Amount
of
contract
or
arrangem
ent
Date of
shareholders
approval if
any
Relation
with
Director /
Company /
Nature of
concern or
Interest
Whether the
transaction
is at arm's
length basis
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
Register of Contracts with Related Party and Contracts and Bodies etc. in which Directors are interested[Pursuant to section 189(1) and Rule 16(1)]
Details of voting on such resolutionDate of
approval
at the
meeting of
the Board
Date of
Contract /
Arrangement
Name of the
party with
which contract
is entered into
Name of
the
Interested
Director
Date of the
next meeting
at which
register was
placed for
signature
Signature Remarks,if
any
Principal terms and conditions
A. Contracts or agreements with any Related Party under section 188 or in which any Director is concerned or interested under sub - section (2) of section 184
![[XLS] micr.xlsx · Web viewAJMER MAIN JLN.HOSPI.RD BRANCH AKLUJ AKOTA-BARODA KANDIVLI-EST BRANCH BANSMANDI, ALLAHABAD ALIPURA ALIPORE ALIGARH BRANCH ALKAPURI BRANCH ALLABAD MAIN BRANCH](https://static.documents.pub/doc/80x56/5ab79b957f8b9ac10d8beef0/xls-micrxlsxweb-viewajmer-main-jlnhospird-branch-akluj-akota-baroda-kandivli-est.jpg)
![IPR and Public-Private Technology Transfer Professor Prabuddha Ganguli [PhD] CEO VISION-IPR 103 B SENATE, Lokhandwala Township, Akurli Road, Kandivli East,](https://static.documents.pub/doc/80x56/551545bf55034673228b602f/ipr-and-public-private-technology-transfer-professor-prabuddha-ganguli-phd-ceo-vision-ipr-103-b-senate-lokhandwala-township-akurli-road-kandivli-east.jpg)
